Diapharma/Technoclone Anti-uPA Polyclonal Antibody, 1mg/TC31014/Vial/1mg

Description:

TechnocloneAnti-uPAPolyclonalAntibody,1mg

Reactswithurokinaseanditscomplexes;noreactionwithotherplasmaproteins. CanbeusedasprecipitatingantibodyinRIA(2,3),asantibodyinanELISA(3)orforimmunoaffinitypurificationofurokinase(4).

Immunizingantigen

Highmolecularweighturokinase

Immunizedspecies

Rabbit

Purification

TheantibodyispurifiedfromrabbitserumbyammoniumsulphateprecipitationfollowedbyDEAEion-exchangechromatography.

Characteristicsoftheantibody

(1)Reactswithhighandlowmolecularweighturokinaseaswellwithscu-PA(urine,tissuecultureandrecombinant);alsoreactswithu-PAinhibitorcomplexes.

Handlingandstorage:

Theantibodyislyophilizedfroma1mg/mlsolutioninisotonicphosphatebufferedsaline,pH7.4,containing0.02%sodiumazideand20mg/mlmannitol.Itissuppliedinvialsof1mgandshouldbereconstitutedwith1mLdistilledwater.

Forextensivedilutionsaproteincontainingsolutionshouldbeused(e.g.1%bovineserumalbumininPBS).

Lyophilizedantibodyshouldbestoredat4°C.Reconstitutedantibodyshouldbealiquotedandstoredat-20°Corlower.Avoidrepeatedfreeze-thawcycles.

Literature:

1)K.Huber,J.Kirchheimer,B.R.Binder:Rapidisolationofhighmolecularweighturokinasefromnativehumanurine.Thromb.Haemost.47:197–202,1982.

2)K.Huber,J.Kirchheimer,B.R.Binder:Characterizationofaspecificanti-humanurokinaseantibody:developmentofasensitivecompetitionrADIoimmunoassayforurokinaseantigen.J.Lab.Clin.Med.103:684–694,1984.

3)J.Wojta,B.R.Binder,K.Huber,R.L.Hoover:Evaluationoffibrinolyticcapacityinplasmaduringthrombolytictherapywithsingle(scu-PA)ortwochainurokinasetypeplasminogenactivator(tcu-PA)byacombinedassaysystemforurokinasetypeplasminogenactivatorantigenandfunction.Thromb.Haemost.61:289-293,1989.

4)B.Grasl,M.Jörg,B.R.Binder:Isolationofaplasminogenactivatorfromhumanplasmabyaffinitychromatographyonanti-urokinase-Sepharose.Partialcharacterizationoftheenzyme.In:Progressinfibrinolysis,Vol.6,ChurchillLivingstone,Edinburgh,London,Melbourne,NewYork,pp.50-53,1983.